| Rakshak Sarda, MD | |
|
1816 Philadelphia St, Ames, IA 50010-8771 | |
| (515) 232-2500 | |
| (515) 246-4479 |
| Full Name | Rakshak Sarda |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 1816 Philadelphia St, Ames, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114948338 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Greeley Medical Center | Ames, IA | Hospital |
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Boone County Hospital | Boone, IA | Hospital |
| Ottumwa Regional Health Center | Ottumwa, IA | Hospital |
| Davis County Hospital | Bloomfield, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Health Initiatives-iowa Corp | 5698683142 | 112 |
News Archive
The rate of COVID-19 positivity among young adults has been higher than other age groups during July and August. And, while the West Virginia University community is no stranger to doing its part to help suppress the positivity rate and keep others safe, there are significant factors that may result in WVU students letting down their guard when it comes to mitigation strategies - in particular, wearing a mask.
"Finding quality health care continues to be a challenge in the New Orleans area. Five years ago, Hurricane Katrina flooded area hospitals, destroyed buildings and scattered patients. The health care industry has been slow to recover and in some cases, facilities still haven't opened. …
Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children. The large multicenter study defines the genetic landscape of this cancer, and holds intriguing clues to gene changes on signaling pathways that may become fruitful targets for future therapies.
Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.
› Verified 3 days ago
| Entity Name | Catholic Health Initiatives-iowa Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508964883 PECOS PAC ID: 5698683142 Enrollment ID: O20031118000163 |
News Archive
The rate of COVID-19 positivity among young adults has been higher than other age groups during July and August. And, while the West Virginia University community is no stranger to doing its part to help suppress the positivity rate and keep others safe, there are significant factors that may result in WVU students letting down their guard when it comes to mitigation strategies - in particular, wearing a mask.
"Finding quality health care continues to be a challenge in the New Orleans area. Five years ago, Hurricane Katrina flooded area hospitals, destroyed buildings and scattered patients. The health care industry has been slow to recover and in some cases, facilities still haven't opened. …
Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children. The large multicenter study defines the genetic landscape of this cancer, and holds intriguing clues to gene changes on signaling pathways that may become fruitful targets for future therapies.
Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rakshak Sarda, MD 1816 Philadelphia St, Ames, IA 50010-8771 Ph: (515) 232-2500 | Rakshak Sarda, MD 1816 Philadelphia St, Ames, IA 50010-8771 Ph: (515) 232-2500 |
News Archive
The rate of COVID-19 positivity among young adults has been higher than other age groups during July and August. And, while the West Virginia University community is no stranger to doing its part to help suppress the positivity rate and keep others safe, there are significant factors that may result in WVU students letting down their guard when it comes to mitigation strategies - in particular, wearing a mask.
"Finding quality health care continues to be a challenge in the New Orleans area. Five years ago, Hurricane Katrina flooded area hospitals, destroyed buildings and scattered patients. The health care industry has been slow to recover and in some cases, facilities still haven't opened. …
Pediatric cancer researchers at The Children's Hospital of Philadelphia contributed important expertise to a new landmark study of medulloblastoma, a type of brain tumor typically found in children. The large multicenter study defines the genetic landscape of this cancer, and holds intriguing clues to gene changes on signaling pathways that may become fruitful targets for future therapies.
Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.
› Verified 3 days ago
Dr. Alexander C Flower, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2315 167th Pl, Ames, IA 50014 Phone: 515-720-7755 Fax: 515-875-4005 | |
Dr. Danielle L Pellow, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Avenue, Ames, IA 50010 Phone: 515-239-4432 Fax: 515-239-4754 | |
Dr. Austin Greco, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1111 Duff Ave, Ames, IA 50010 Phone: 515-239-4401 Fax: 515-239-4791 | |
Louis Walter Banitt, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2514 Kellogg Ave, Ames, IA 50010 Phone: 515-232-1122 | |
Dr. Todd Clinton Berryhill, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4432 Fax: 515-239-4754 | |
Dr. Venkatesh K. Rudrapatna, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1111 Duff Avenue, Ames, IA 50010 Phone: 515-239-4401 Fax: 515-239-4791 |